Organon (OGN) Times Interest Earned (2021 - 2026)
Organon (OGN) posted quarterly Times Interest Earned of $2.12 for Q1 2026, up 9.84% year-over-year from $1.93 in Q1 2025, and up 21.99% on a QoQ basis from $1.74 in Q4 2025.
Organon (OGN) Times Interest Earned (2021 - 2026) Analysis & Trends
Organon (OGN) has reported Times Interest Earned for 6 consecutive years, with $2.12 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 9.84% year-over-year to $2.12; the TTM figure through Mar 2026 stood at $2.3 (down 11.07% YoY), while the FY2025 annual figure was $2.24, up 590.48% from the prior year.
- Times Interest Earned came in at $2.12 for Q1 2026 at Organon, up from $1.74 in the prior quarter.
- The five-year high for Times Interest Earned was $3.26 in Q3 2024, with the low at -$4.49 in Q4 2023.
- Average Times Interest Earned over 5 years is -$0.51, with a median of -$1.23 recorded in 2022.
- Across the five-year window, Times Interest Earned plunged 113.04% in 2023 and soared 200.76% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$4.06 in 2022, then fell by 10.58% to -$4.49 in 2023, then soared by 148.61% to $2.18 in 2024, then retreated by 20.45% to $1.74 in 2025, then gained by 21.99% to $2.12 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $2.12, $1.74, and $2.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 23.39 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -10.80 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Organon | 3.53 Bn | 2.41 Bn | 783.00 Mn | 2.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.12 |
| Dec 31, 2025 | 1.74 |
| Sep 30, 2025 | 2.80 |
| Jun 30, 2025 | 2.47 |
| Mar 31, 2025 | 1.93 |
| Dec 31, 2024 | 2.18 |
| Sep 30, 2024 | 3.26 |
| Jun 30, 2024 | 2.95 |
| Mar 31, 2024 | -3.27 |
| Dec 31, 2023 | -4.49 |
| Sep 30, 2023 | -3.97 |
| Jun 30, 2023 | -2.92 |
| Mar 31, 2023 | -2.61 |
| Dec 31, 2022 | -4.06 |
| Sep 30, 2022 | -2.49 |
| Jun 30, 2022 | -3.07 |
| Mar 31, 2022 | -1.23 |
| Dec 31, 2021 | -3.70 |
| Sep 30, 2021 | -2.24 |
| Jun 30, 2021 | -2.35 |